Kate Merritt1, Pedro Luque Laguna2, Ayela Irfan1, Anthony S David1. 1. Division of Psychiatry, Institute of Mental Health, University College London, London, United Kingdom. 2. The Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, United Kingdom.
Abstract
Background: Several cross-sectional studies report brain structure differences between healthy volunteers and subjects at genetic or clinical high risk of developing schizophrenia. However, longitudinal studies are important to determine whether altered trajectories of brain development precede psychosis onset. Methods: We conducted a systematic review to determine if brain trajectories differ between (i) those with psychotic experiences (PE), genetic (GHR) or clinical high risk (CHR), compared to healthy volunteers, and (ii) those who transition to psychosis compared to those who do not. Results: Thirty-eight studies measured gray matter and 18 studies measured white matter in 2,473 high risk subjects and 990 healthy volunteers. GHR, CHR, and PE subjects show an accelerated decline in gray matter primarily in temporal, and also frontal, cingulate and parietal cortex. In those who remain symptomatic or transition to psychosis, gray matter loss is more pronounced in these brain regions. White matter volume and fractional anisotropy, which typically increase until early adulthood, did not change or reduced in high risk subjects in the cingulum, thalamic radiation, cerebellum, retrolenticular part of internal capsule, and hippocampal-thalamic tracts. In those who transitioned, white matter volume and fractional anisotropy reduced over time in the inferior and superior fronto-occipital fasciculus, corpus callosum, anterior limb of the internal capsule, superior corona radiate, and calcarine cortex. Conclusion: High risk subjects show deficits in white matter maturation and an accelerated decline in gray matter. Gray matter loss is more pronounced in those who transition to psychosis, but may normalize by early adulthood in remitters.
Background: Several cross-sectional studies report brain structure differences between healthy volunteers and subjects at genetic or clinical high risk of developing schizophrenia. However, longitudinal studies are important to determine whether altered trajectories of brain development precede psychosis onset. Methods: We conducted a systematic review to determine if brain trajectories differ between (i) those with psychotic experiences (PE), genetic (GHR) or clinical high risk (CHR), compared to healthy volunteers, and (ii) those who transition to psychosis compared to those who do not. Results: Thirty-eight studies measured gray matter and 18 studies measured white matter in 2,473 high risk subjects and 990 healthy volunteers. GHR, CHR, and PE subjects show an accelerated decline in gray matter primarily in temporal, and also frontal, cingulate and parietal cortex. In those who remain symptomatic or transition to psychosis, gray matter loss is more pronounced in these brain regions. White matter volume and fractional anisotropy, which typically increase until early adulthood, did not change or reduced in high risk subjects in the cingulum, thalamic radiation, cerebellum, retrolenticular part of internal capsule, and hippocampal-thalamic tracts. In those who transitioned, white matter volume and fractional anisotropy reduced over time in the inferior and superior fronto-occipital fasciculus, corpus callosum, anterior limb of the internal capsule, superior corona radiate, and calcarine cortex. Conclusion: High risk subjects show deficits in white matter maturation and an accelerated decline in gray matter. Gray matter loss is more pronounced in those who transition to psychosis, but may normalize by early adulthood in remitters.
Keywords:
DTI; MRI; clinical high risk (CHR); genetic high risk for psychosis; high risk psychosis; neuroimaging; psychotic like experiences; ultra high risk (UHR)
Authors: E C Johnstone; S S Abukmeil; M Byrne; R Clafferty; E Grant; A Hodges; S M Lawrie; D G Owens Journal: Schizophr Res Date: 2000-11-30 Impact factor: 4.939
Authors: Anna M Hedman; Neeltje E M van Haren; G Caroline M van Baal; Rachel M Brouwer; Rachel G H Brans; Hugo G Schnack; René S Kahn; Hilleke E Hulshoff Pol Journal: Schizophr Res Date: 2015-07-26 Impact factor: 4.939
Authors: Yoonho Chung; Aron Jacobson; George He; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen; Tyrone D Cannon Journal: Mol Neuropsychiatry Date: 2015-05-01
Authors: Anand A Mattai; Brian Weisinger; Deanna Greenstein; Reva Stidd; Liv Clasen; Rachel Miller; Julia W Tossell; Judith L Rapoport; Nitin Gogtay Journal: J Am Acad Child Adolesc Psychiatry Date: 2011-06-11 Impact factor: 8.829
Authors: Nitin Gogtay; Xue Hua; Reva Stidd; Christina P Boyle; Suh Lee; Brian Weisinger; Alex Chavez; Jay N Giedd; Liv Clasen; Arthur W Toga; Judith L Rapoport; Paul M Thompson Journal: Arch Gen Psychiatry Date: 2012-09
Authors: Sarah A Sullivan; Daphne Kounali; Mary Cannon; Anthony S David; Paul C Fletcher; Peter Holmans; Hannah Jones; Peter B Jones; David E J Linden; Glyn Lewis; Michael J Owen; Michael O'Donovan; Alexandros Rammos; Andrew Thompson; Dieter Wolke; Jon Heron; Stanley Zammit Journal: Am J Psychiatry Date: 2020-01-07 Impact factor: 18.112
Authors: Justin Davis; Harris Eyre; Felice N Jacka; Seetal Dodd; Olivia Dean; Sarah McEwen; Monojit Debnath; John McGrath; Michael Maes; Paul Amminger; Patrick D McGorry; Christos Pantelis; Michael Berk Journal: Neurosci Biobehav Rev Date: 2016-04-09 Impact factor: 8.989